| Members |
targetComponentId |
| Poison mushroom |
Order Agaricales |
| Poisoning by Centruroides sculpturatus |
Poisoning by Centruroides exilicauda |
| Poisoning by acetylsalicylic acid |
Poisoning by salicylate |
| Poisoning by acidifying agent |
Poisoning |
| Poisoning by antirheumatic, NEC |
Poisoning by antirheumatic |
| Poisoning by arthropod bite |
Poisoning due to arthropod venom |
| Poisoning by drug AND/OR biological |
Poisoning by drug AND/OR medicinal substance |
| Poisoning by electrolytic, caloric and water-balanced agent, NEC |
Poisoning by drug AND/OR medicinal substance |
| Poisoning by enzyme, NEC |
Poisoning by enzyme |
| Poisoning by other psychotropic agent, NEC |
Poisoning by psychotropic agent |
| Poisoning by salicylic acid salt |
Poisoning by salicylate |
| Poisoning by tranquilizer, NEC |
Poisoning by tranquilizer |
| Poisoning by vitamin, NEC |
Poisoning by vitamin |
| förgiftning orsakad av alkaliserande medel |
Poisoning |
| förgiftning orsakad av antibiotikum i gruppen kloramfenikoler |
Poisoning by chloramphenicol |
| förgiftning orsakad av synergieffekt av flera kemikalier |
Poisoning |
| Politzerization - action |
Inflation - action |
| polyartikulär juvenil reumatoid artrit |
Polyarticular juvenile idiopathic arthritis |
| Polyarticular juvenile rheumatoid arthritis |
Polyarticular juvenile idiopathic arthritis |
| Polyarticular onset juvenile chronic arthritis |
Polyarticular juvenile idiopathic arthritis |
| polyklonalt genrearrangemang |
T cell gene rearrangement analysis (procedure) |
| Polycythemia neonatorum |
Neonatal polycythemia |
| Polycythemia vera |
Polycythemia vera |
| polyetylenglykol 3350, 100 %, pulver |
Macrogol 3350 only product |
| Polyhydramnios NOS |
Polyhydramnios |
| Polyhydramnios NOS |
Polyhydramnios |
| Polyhydramnios unspecified |
Polyhydramnios |
| polymetylmetakrylatmikrosfärer 20 % + bovint kollagen 3,5 %, injektionsvätska, lösning, förfylld spruta |
Product containing only bovine collagen and polymethyl methacrylate (medicinal product) |
| polymyxin B-sulfat 500 000 IE, pulver till injektionsvätska, flaska |
Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial |
| Polymyxin b sulfate + trimethoprim sulfate |
Product containing polymyxin B and trimethoprim (medicinal product) |
| Polyomavirus group |
Genus Polyomavirus (organism) |
| Polyomavirus hominis |
Genus Polyomavirus (organism) |
| polyfagisymtom |
Excessive eating |
| polysomatöst missbildat foster |
Polysomia (disorder) |
| polyvinylalkohol 1,4 %, ögondroppar |
Product containing precisely polyvinyl alcohol 14 microliter/1 milliliter conventional release eye solution (clinical drug) |
| polyvinylalkohol 1,4 %, ögondroppar för engångsbruk |
Product containing precisely polyvinyl alcohol 14 microliter/1 milliliter conventional release eye solution (clinical drug) |
| havsbraxen eller svartfisk, livsmedel |
Pomfret (substance) |
| Poor concentration |
Poor concentration |
| Poor concentration |
Poor concentration |
| Poor concentration |
Poor concentration |
| Poor labor contractions |
Uterine inertia |
| långsam metaboliserare på grund av cytokrom P450, variant CYP2C19 |
Cytochrome P450 family 2 subfamily C member 19 poor metabolizer (finding) |
| långsam metaboliserare på grund av cytokrom P450, variant CYP2C9 |
Cytochrome P450 family 2 subfamily C member 9 poor metabolizer (finding) |
| långsam metaboliserare på grund av cytokrom P450, variant CYP2D6 |
Cytochrome P450 family 2 subfamily D member 6 poor metabolizer (finding) |
| porcin faktor VIII, 700 IE, pulver och vätska till injektionsvätska, lösning, flaska |
Product containing only porcine factor VIII in parenteral dose form (medicinal product form) |
| antikropp mot PRRS-virus |
Anti viral antibody |
| Lamberts syndrom |
Ichthyosis hystrix gravior (disorder) |
| porfyriliknande reaktion på gift och/eller miljötoxin |
Pseudoporphyria |
| Porphyromonas asaccharolyticus |
Porphyromonas asaccharolytica (organism) |
| Porphyromonas assacharolytica |
Porphyromonas asaccharolytica (organism) |
| Porphyromonas endodontalis |
Porphyromonas endodontalis |
| Porpoise distemper virus |
Cetacean morbillivirus (organism) |
| Portable electroencephalogram awake and asleep with hyperventilation and/or photic stimulation |
Portable electroencephalogram awake and asleep with stimulation |
| Portable electroencephalogram awake and drowsy with hyperventilation and/or photic stimulation |
Portable electroencephalogram awake and drowsy with stimulation |
| injektion i venport |
Implantable venous access port injection |
| manlig urinrörsmynnings läge |
Position of male external urethral orifice (observable entity) |
| PET-undersökning av myokardiet i vila med ^81^Rb |
Positron emission tomography myocardial rest imaging using rubidium-82 (procedure) |
| PET-undersökning av myokardiet under belastning med ^81^Rb |
Positron emission tomography myocardial stress imaging using rubidium-82 (procedure) |
| PET-undersökning med datortomografi av myokardiet i vila med ^81^Rb |
Positron emission tomography with computed tomography myocardial rest imaging using rubidium-82 (procedure) |
| PET-undersökning med datortomografi av myokardiet under belastning med ^81^Rb |
Positron emission tomography with computed tomography myocardial stress imaging using rubidium-82 (procedure) |
| möjlig graviditet |
Possible pregnancy |
| lymfoproliferativ sjukdom efter transplantation |
Post-transplantation lymphoproliferation (morphologic abnormality) |
| Post-delivery acute renal failure NOS |
Postpartum acute renal failure (disorder) |
| Post-delivery acute renal failure unspecified |
Postpartum acute renal failure (disorder) |
| posttranslationell genetisk RNA-modifiering |
Post-transcriptional genetic ribonucleic acid processing (finding) |
| perikardit efter hjärtskada |
Post-cardiac injury syndrome (disorder) |
| postkardiotomisyndrom |
Post-pericardiotomy syndrome |
| Postcardiotomy syndrome |
Post-pericardiotomy syndrome |
| Postcardiotomy syndrome |
Post-pericardiotomy syndrome |
| Postcoital bleeding |
Postcoital bleeding |
| Posterior cervical cord injury without bony injury, C5-7 |
Posterior cervical spinal cord injury without spinal bone injury, C5-7 (disorder) |
| Posterior cervical cord injury, without bony injury, C1-4 |
Posterior cervical spinal cord injury, without spinal bone injury, C1-4 (disorder) |
| bakre cervikal lambå |
Flap (substance) |
| bakre bröstkorgslambå |
Flap (substance) |
| fasciokutan arteria interossea posterior-lambå samt radius |
Osteofasciocutaneous flap (substance) |
| Posterior ligament of iris |
Trabecular meshwork structure |
| bakre lårlambå |
Flap (substance) |
| bakre tibialambå |
Posterior tibial artery flap |
| ökad halt av substans i blodet post mortem |
Blood substance level above reference range |
| postnatal anti-D-profylax avböjd |
Administration of human anti-D immunoglobulin declined |
| postoperativ cellulit i operationssår |
Postoperative wound cellulitis |
| postoperativa åtgärder |
Postoperative procedure (procedure) |
| Postoperative pulmonary edema |
Postoperative pulmonary edema |
| Postpartum coagulation defects NOS |
Postpartum coagulation defects |
| Postpartum coagulation defects unspecified |
Postpartum coagulation defects |
| risk under postpartumperioden |
At increased risk for postpartum disorder (finding) |
| intraabdominell sepsis efter åtgärd |
Intra-abdominal infection following surgical procedure |
| Posttraumatic wound infection, NEC |
Post-traumatic wound infection |
| Postural proteinuria |
Orthostatic proteinuria (finding) |
| kalium 6,5 millimol, brustablett |
Potassium only product in oral dose form |
| kaliumallergi |
Propensity to adverse reaction to potassium (finding) |
| kaliumvätekarbonat 1,39 g + citronsyra 1,14 g, löslig tablett |
Citric acid and potassium bicarbonate only product in oral dose form |
| kaliumklorid 10 %, injektionsvätska, lösning, ampull |
Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| kaliumklorid 10 milliekvivalenter, tablett med modifierad frisättning |
Product containing only potassium chloride in oral dose form (medicinal product form) |
| kaliumklorid 10 milliekvivalenter, depåtablett |
Product containing only potassium chloride in oral dose form (medicinal product form) |
| dextros 4 % + kaliumklorid 10 mmol , infusionsvätska, lösning, påse 500 ml |
Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
| dextros 5 % + kaliumklorid 10 mmol, infusionsvätska, lösning, påse 500 ml |
Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter and sodium chloride 4.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| glukos 5 % + kaliumklorid 10 mmol, infusionsvätska, lösning, påse 500 ml |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for injection |
| natriumklorid 0,9 % + kaliumklorid 10 mmol, infusionsvätska, lösning, påse 500 ml |
Product containing precisely potassium chloride 1.5 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Potassium chloride 1500mg |
Product containing precisely potassium chloride 1.5 gram/1 each conventional release oral tablet (clinical drug) |
| Potassium chloride 15meq |
Potassium chloride only product |
FHIR